Human Epidermal Growth Factor Receptor 2 (HER2) - Class II - ANVISA Registration 10345162280
Access comprehensive regulatory information for Human Epidermal Growth Factor Receptor 2 (HER2) - Class II in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10345162280 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The registration is held by SIEMENS HEALTHCARE DIAGNÓSTICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
10345162280
25351087054201850
01449930000190
Company Information
Dates and Status
May 28, 2018
VIGENTE
09/18/2025 19:00:01
HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)
Família MAGLUMI HER-2 (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513361
Jan 27, 2025
HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)
Família MAGLUMI HER-2 (CLIA)
Not specified
80102513361
Jan 27, 2025
CA 15-3 ANTIGEN
Família Atellica IM CA 15-3 (CA 15-3)
Not specified
10345162242
Apr 30, 2018
CA 15-3 ANTIGEN
Família Atellica IM CA 15-3 (CA 15-3)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162242
Apr 30, 2018
CA 27-29 ANTIGEN
Família Atellica IM BR 27.29
Not specified
10345162264
May 07, 2018